Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia

BACKGROUND: Data from a randomized multinational phase 3 trial of 320 adults with acute myeloid leukemia (AML) demonstrated that maintenance therapy with 3-week cycles of histamine dihydrochloride plus low-dose interleukin-2 (HDC/IL-2) for up to 18 months significantly improved leukemia-free surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Buyse, Marc, Squifflet, Pierre, Lucchesi, Kathryn J, Brune, Mats L, Castaigne, Sylvie, Rowe, Jacob M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077323/
https://www.ncbi.nlm.nih.gov/pubmed/21429214
http://dx.doi.org/10.1186/1745-6215-12-86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077323/
https://www.ncbi.nlm.nih.gov/pubmed/21429214
http://dx.doi.org/10.1186/1745-6215-12-86

Ejemplares similares